|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| (11) | Number of the document | 2949666 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15166032.1 |
| Date of filing the European patent application | 2009-12-21 | |
| (97) | Date of publication of the European application | 2015-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation | 2019-07-10 |
| (30) | Number | Date | Country code |
| 08022188 | 2008-12-19 | EP | |
| 13925308 P | 2008-12-19 | US |
| (72) |
Weihofen, Andreas, CH
Grimm, Jan, CH
Nitsch, Roger, CH
Hock, Christoph, CH
|
| (73) |
University of Zurich,
Rämistr. 71, 8006 Zurich,
CH
Biogen International Neuroscience GmbH, Neuhofstrasse 30, 6340 Baar, CH |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Žmogaus anti-alfa-sinukleino antikūnai |
| HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2022-11-22 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-01-26 |